Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • HESmith
    Senior Member
    • Oct 2009
    • 512

    #16
    Originally posted by danwiththeplan View Post
    If you already have the sequencing done you obviously can't do this, but adding spike-in controls would go a long way to letting you compare expression levels across datasets. Also, biological reps.
    Actually, no. Spike-ins are only useful for validating the reproducibility of library construction (i.e., technical replicates). They tell you nothing about how much transcript levels vary b/t samples (biological replicates).

    Comment

    • danwiththeplan
      Member
      • Sep 2011
      • 72

      #17
      Originally posted by HESmith View Post
      Actually, no. Spike-ins are only useful for validating the reproducibility of library construction (i.e., technical replicates). They tell you nothing about how much transcript levels vary b/t samples (biological replicates).
      Well, my understanding was that spike-ins (ERCC spike ins like this: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166838/) allow you to control for effects that would otherwise go undetected between runs (gc content, length effects, concentration effects), whether those runs are biological or technical reps, and that spike-ins would allow you to detect these effects from the point that they are spiked in (which should be as soon as possible), so, they are useful for validating all of the steps from that point onwards (i.e. polyA purification, ribodepletion, library construction). But maybe I misunderstood and I'm open to being corrected.

      Plus, I'm not sure why anyone would do technical reps anyway when there's so much more value to be gained from another biological rep.
      Last edited by danwiththeplan; 03-14-2013, 01:59 PM.

      Comment

      • HESmith
        Senior Member
        • Oct 2009
        • 512

        #18
        Okay, my answer was clearly too terse. When RNA-Seq data indicate a difference in gene expression, there are two potential causes: biological (i.e., transcript levels go up or down in the cell/tissue/organism), and technical (changes introduced on the path from nucleic acid isolation to sequence generation). Spike-in controls are useful for detecting/validating the points you mention, but those are all technical aspects of the experiment. Spike-ins do contribute to the biological basis for the observed difference, but only in the sense of eliminating technical bias as the culprit.

        Comment

        • danwiththeplan
          Member
          • Sep 2011
          • 72

          #19
          Originally posted by HESmith View Post
          Okay, my answer was clearly too terse. When RNA-Seq data indicate a difference in gene expression, there are two potential causes: biological (i.e., transcript levels go up or down in the cell/tissue/organism), and technical (changes introduced on the path from nucleic acid isolation to sequence generation). Spike-in controls are useful for detecting/validating the points you mention, but those are all technical aspects of the experiment. Spike-ins do contribute to the biological basis for the observed difference, but only in the sense of eliminating technical bias as the culprit.
          Yep. Well put.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            10-14-2026, 09:55 AM
          • SEQadmin2
            New Genomics Technologies Take Aim at Long-Standing Limits
            by SEQadmin2


            Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

            We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
            ...
            09-28-2026, 10:25 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 10-22-2026, 11:13 AM
          0 responses
          26 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-22-2026, 10:48 AM
          0 responses
          20 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-15-2026, 10:52 AM
          0 responses
          36 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-14-2026, 05:39 AM
          0 responses
          43 views
          0 reactions
          Last Post SEQadmin2  
          Working...